immunoSEQ offers researchers around the world a powerful new tool in understanding adaptive immunity. SEATTLE, WA, October 17, 2011 – A new study published in The Journal of Immunological Methods demonstrates conclusively that immunoSEQ, Adaptive TCR Corporation’s breakthrough solution for immune profiling, provides a sensitive, reliable method for researchers to accurately evaluate overall T cell [...]

Experienced, respected leaders in their fields help position Adaptive for strong growth. SEATTLE, WA, September 29, 2011 – Adaptive TCR Corporation, a leading provider of online solutions for large scale immune system profiling under the brand name immunoSEQ, announced today several high profile additions to its Board of Directors, Corporate Advisory Board, and Scientific Advisory [...]

On August 10, 2011, researchers at the University of Pennsylvania published two groundbreaking studies in the New England Journal of Medicine and Science Translational Medicine on a potential cure for leukemia. Dr. Walter J. Urba of the Providence Cancer Center in Portland, Oregon, and editorialist at The New England Journal of Medicine called the findings [...]

SEATTLE, WA, June 9, 2011 – Adaptive TCR Corporation (www.adaptivetcr.com), a leading provider of online solutions for large scale immune system profiling under the brand name immunoSEQ, announced today that it has completed its Series B investment round, raising $5.8 million from private investors, adding to its previous $4.5 million financing announced in March 2010. [...]

Former Senior Director of Global Oncology Commercial Development at Pfizer Signals Company’s Focus on Oncology Commercial Applications. SEATTLE, WA, May 9, 2011 – Adaptive TCR Corporation, a leading provider of online solutions for large scale immune system profiling under the brand name immunoSEQ, has named Julie Rubinstein as its new Vice President of Business Development, Oncology. [...]

Adaptive TCR Corporation Announces QTDP Grant Awards of Over $1.0 million to Utilize Next Generation Sequencing Immune Profiling Assay for Several Projects Seattle, WA – Adaptive TCR Technologies, a biotech firm based in Seattle, WA, announced today that it has received a total of $1,047,054 in Qualifying Therapeutic Discovery Program (QTDP) grants for five (5) [...]

Seattle, WA – Adaptive TCR Technologies, a biotech firm based in Seattle, WA, announced today that Craig Weissman is joining the Board of Directors. Craig is the Chief Technology Officer of Salesforce.com, one of the best performing technology companies of the past decade. “We are thrilled that Mr. Weissman has joined our Board,” offers Chad [...]

Seattle, WA  September 1, 2010 — A new study published in Science Translational Medicine highlights the kind of important insight that can be gained from an application of the immunoSEQTM immune system profiling technology. The study was authored by Harlan Robins, PhD, a faculty member at the Fred Hutchinson Cancer Research Center and a co-founder of Adaptive [...]

Seattle, WA – Adaptive TCR Corporation announced today that it will offer multiple immune profiling services at various price points to accommodate scientific investigators studying a wide range of topics, with varying budgets. Specifically, the Company will provide four levels of sequencing services, based on the investigator’s desired number of reads, at different price points. [...]

Palo Alto, CA – Chad Robins, Founder and CEO of Adaptive TCR Corporation in Seattle, WA, delivered an address entitled “A Day in the Life: Lessons from an Early Stage Biotech Entrepreneur” to the healthcare club at the Graduate School of Business at Stanford University today. Speaking to a cross-disciplinary audience consisting of MBAs, MDs, [...]